They reported that oxidized LDL is cytotoxic and reduces cholinergic transmission rate in AD and that using anti-oxidant/anti-hyperlipidemic treatments to inhibit AChE, can be a suitable solution (Yamchuen et al., 2014). The gene discussed is ACHE; the disease is Alzheimer disease.